Fridays offers clinically backed GLP-1 treatments that help regulate appetite, improve metabolism, and support sustainable weight loss
The TRIUMPH clinical trial program is evaluating retatrutide for multiple indications beyond simple weight loss, including obesity with osteoarthritis, obesity with metabolic complications, type 2 diabetes, cardiovascular outcomes, obstructive sleep apnea, and metabolic dysfunction-associated steatohepatitis
It comes as a tablet, not a liquid, but many people search for "GLP-1 oral liquid" when they actually mean any oral GLP-1 formulation
The program is medically facilitated, ACLM-certified, and grounded in the science of whole-food plant-based nutrition
The plaintiffs proposed this expansion to consolidate claims of potential blood clot-related injuries allegedly linked to these drugs